| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total current assets | 504,604 | 538,832 | ||
| Other non-current assets | 0 | 0 | ||
| Total assets | 504,604 | 538,832 | ||
| Total stockholders equity | 455,100 | 455,773 | ||
| Total liabilities, convertible preferred stock and stockholders equity | 504,604 | 538,832 | ||
Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE)